Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-02-15 | Ronald M. Cresswell is listed as a director with no mention of software or technical background. |
| 2011-04-14 | He earned B.Sc. and Ph.D. degrees in applied chemistry at the University of Glasgow. He completed post-doctoral work in the field of nucleoprotein chemistry at Sloan Kettering Hospital in New York and is a graduate of the Harvard Advanced Management Program. |
| 2012-04-16 | He earned B.Sc. and Ph.D. degrees in applied chemistry at the University of Glasgow. He completed post-doctoral work in the field of nucleoprotein chemistry at Sloan Kettering Hospital in New York and is a graduate of the Harvard Advanced Management Program. |
| 2013-03-22 | He earned B.Sc. and Ph.D. degrees in applied chemistry at the University of Glasgow. He completed post-doctoral work in the field of nucleoprotein chemistry at Sloan Kettering Hospital in New York. |
| 2013-09-05 | Ronald M. Cresswell(5) - Includes 236,833 shares issuable upon exercise of options held by Dr. Cresswell that are exercisable within the 60-day period following August 31, 2013. |
| 2014-03-31 | He earned B.Sc. and Ph.D. degrees in applied chemistry at the University of Glasgow. He completed post-doctoral work in the field of nucleoprotein chemistry at Sloan Kettering Hospital in New York and is a graduate of the Harvard Advanced Management Program. |
| 2014-10-21 | Director Compensation table and related descriptions do not mention any software-related technical skills for Ronald M. Cresswell. |
Data sourced from SEC filings. Last updated: 2025-10-11